📰 Nasdaq Dmac News
Page 2 - Nasdaq Dmac News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Dmac. Real-time updates on events, politics, business and more.
May 6, 2023
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of current […]
April 30, 2023
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation. Volatility & Risk DiaMedica Therapeutics has a beta […]
April 17, 2023
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 91,500 shares, an increase of 55.6% from the March 15th total of 58,800 shares. Based on an average daily trading volume, of 31,800 shares, […]
April 13, 2023
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) insider David J. Wambeke purchased 468,750 shares of the company’s stock in a transaction dated Monday, April 10th. The stock was acquired at an average price of $1.60 per share, with a total value of $750,000.00. Following the completion of the transaction, the insider now owns 468,750 shares […]
March 29, 2023
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) posted its quarterly earnings results on Tuesday. The company reported ($0.14) EPS for the quarter, hitting the consensus estimate of ($0.14), Yahoo Finance reports. During the same quarter in the previous year, the company earned ($0.10) EPS. DiaMedica Therapeutics Stock Performance DMAC stock opened at $1.52 on Wednesday. The […]
March 27, 2023
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) is scheduled to post its quarterly earnings results after the market closes on Tuesday, March 28th. Analysts expect DiaMedica Therapeutics to post earnings of ($0.14) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. DiaMedica Therapeutics […]
June 12, 2022
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 51,000 shares, a drop of 50.3% from the May 15th total of 102,700 shares. Based on an average trading volume of 42,400 shares, the short-interest ratio is […]
March 16, 2022
DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) released its quarterly earnings results on Monday. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $0.08, Fidelity Earnings reports. During the same period in the previous year, the business posted ($0.23) EPS. Shares of DMAC opened at $2.30 […]